scholarly journals Recent Advances in the Synthesis of High Boron-Loaded Nucleic Acids for BNCT

2021 ◽  
Vol 9 ◽  
Author(s):  
Darya Sergeevna Novopashina ◽  
Mariya Alexandrovna Vorobyeva ◽  
Alya Venyaminova

Boron clusters attract considerable attention as promising therapeutic tools for boron neutron capture therapy (BNCT). They combine high boron content with high chemical and biological stability, biorthogonality, and low toxicity. The development of oligonucleotide-based constructs and nucleic acid-like molecules, such as oligomeric phosphate diesters, bearing one or multiple boron clusters permits to create potential high boron-loaded agents for BNCT with good bioavailability, specifically interacting with nucleic acids inside the cell. Here, we shortly review the strategies and solutions in the design of oligonucleotide conjugates with boron clusters in light of the requirements for effective BNCT and future prospects of their practical use.

Biomedicines ◽  
2021 ◽  
Vol 9 (7) ◽  
pp. 722
Author(s):  
Natalya V. Gubanova ◽  
Alphiya R. Tsygankova ◽  
Evgenii L. Zavjalov ◽  
Alexander V. Romashchenko ◽  
Yuriy L. Orlov

Boron neutron capture therapy (BNCT) is based on the ability of the boron-10 (10B) isotope to capture epithermal neutrons, as a result of which the isotope becomes unstable and decays into kinetically active elements that destroy cells where the nuclear reaction has occurred. The boron-carrying compounds—L-para-boronophenylalanine (BPA) and sodium mercaptoundecahydro-closo-dodecaborate (BSH)—have low toxicity and, today, are the only representatives of such compounds approved for clinical trials. For the effectiveness and safety of BNCT, a low boron content in normal tissues and substantially higher content in tumor tissue are required. This study evaluated the boron concentration in intracranial grafts of human glioma U87MG cells and normal tissues of the brain and other organs of mice at 1, 2.5 and 5 h after administration of the boron-carrying compounds. A detailed statistical analysis of the boron biodistribution dynamics was performed to find a ‘window of opportunity’ for BNCT. The data demonstrate variations in boron accumulation in different tissues depending on the compound used, as well as significant inter-animal variation. The protocol of administration of BPA and BSH compounds used did not allow achieving the parameters necessary for the successful course of BNCT in a glioma orthotopic xenograft mouse model.


2011 ◽  
Vol 15 (09n10) ◽  
pp. 973-983 ◽  
Author(s):  
N.V.S. Dinesh K. Bhupathiraju ◽  
Vijay Gottumukkala ◽  
Erhong Hao ◽  
Xiaoke Hu ◽  
Frank R. Fronczek ◽  
...  

Two porphyrins of high boron content (OCP and HCP–PEG) were prepared in high yields from the reaction of the corresponding tri- and tetra-(dihydroxyphenyl)porphyrins with zwitterionic cobaltabisdicarbollide [3,3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H11)] . Both porphyrins were found to have low cytotoxicity toward human HEp2 cells, and to localize subcellularly mainly in the cell lysosomes. Animal toxicity investigations using male and female BALB/c mice also revealed low toxicity for both compounds. The determined maximum tolerated dose (MTD) for these boronated porphyrins administered intraperitoneally were 160 mg/kg for OCP and 320 mg/kg for HCP–PEG. Our studies warrant further development of these porphyrins of high boron content, and in particular of HCP–PEG, as boron delivery vehicles for BNCT.


2015 ◽  
Vol 39 (8) ◽  
pp. 6388-6394 ◽  
Author(s):  
Hayato Koganei ◽  
Shoji Tachikawa ◽  
Mohamed E. El-Zaria ◽  
Hiroyuki Nakamura

High boron-content molecules and their encapsulated liposomes.


Molecules ◽  
2020 ◽  
Vol 25 (5) ◽  
pp. 1210 ◽  
Author(s):  
Justo Cabrera-González ◽  
Mahdi Chaari ◽  
Francesc Teixidor ◽  
Clara Viñas ◽  
Rosario Núñez

High boron content systems were prepared by the peripheral functionalisation of 1,3,5-triphenylbenzene (TPB) and octavinylsilsesquioxane (OVS) with two different anionic boron clusters: closo-dodecaborate (B12) and cobaltabisdicarbollide (COSAN). TPB was successfully decorated with three cluster units by an oxonium ring-opening reaction, while OVS was bonded to eight clusters by catalysed metathesis cross-coupling. The resulting compounds were spectroscopically characterised, and their solution-state photophysical properties analysed. For TPB, the presence of COSAN dramatically quenches the fluorescence emission (λem = 369 nm; ΦF = 0.8%), while B12-substituted TPB shows an appreciable emission efficiency (λem = 394 nm; ΦF = 12.8%). For octasilsesquioxanes, the presence of either COSAN or B12 seems to be responsible for ∼80 nm bathochromic shift with respect to the core emission, but both cases show low emission fluorescence (ΦF = 1.4–1.8%). In addition, a remarkable improvement of the thermal stability of OVS was observed after its functionalisation with these boron clusters.


2015 ◽  
Vol 2015 ◽  
pp. 1-8 ◽  
Author(s):  
Fatima Abi-Ghaida ◽  
Sébastien Clément ◽  
Ali Safa ◽  
Daoud Naoufal ◽  
Ahmad Mehdi

A new class of multifunctional silica nanoparticles carrying boron clusters (10-vertex closo-decaborate) and incorporating luminescent centers (fluorescein) has been developed as potential probes/carriers for potential application in boron neutron capture therapy (BNCT). These silica nanoparticles were chargedin situwith silylated-fluorescein fluorophoresviathe Stöber method and their surface was further functionalized with decaborate-triethoxysilane precursors. The resulting decaborate dye-doped silica nanoparticles were characterized by TEM, solid state NMR, DLS, nitrogen sorption, elemental analysis, and fluorescence spectroscopy.


2015 ◽  
Vol 87 (2) ◽  
pp. 163-171 ◽  
Author(s):  
René Frank ◽  
Verena Ahrens ◽  
Solveig Boehnke ◽  
Sven Hofmann ◽  
Martin Kellert ◽  
...  

AbstractDicarba-closo-dodecaboranes(12) (C2B10H12, carbaboranes) are highly hydrophobic and stable icosahedral carbon-containing boron clusters. The cage framework of these clusters can be modified with a variety of substituents, both at the carbon and at the boron atoms. Substituted carbaboranes are of interest in medicine as boron neutron capture therapy (BNCT) agents or as pharmacophores. High and selective accumulation in tumour cells is an important requirement for a BNCT agent and is achieved by incorporating boron-rich, water-soluble carbaborane derivatives into breast tumour-selective modified neuropeptide Y, [F7, P34]-NPY. Preliminary studies showed that the receptor binding affinity and signal transduction of the boron-modified peptides were very well retained. Use of carbaboranes as pharmacophores was shown by replacement of Bpa32 (Bpa=benzoylphenylalanine) in the reduced-size NPY analogue [Pro30, Nle31, Bpa32, Leu34]-NPY 28–36 by ortho-carbaboranyl propanoic acid. The inclusion of the carbaborane derivative resulted in a short NPY agonist with an interesting hY2R/hY4R preference. This might be a promising approach in the field of anti-obesity drug development.


Molecules ◽  
2017 ◽  
Vol 22 (9) ◽  
pp. 1393 ◽  
Author(s):  
Damian Kaniowski ◽  
Katarzyna Ebenryter-Olbińska ◽  
Milena Sobczak ◽  
Błażej Wojtczak ◽  
Sławomir Janczak ◽  
...  

2012 ◽  
Vol 24 (1) ◽  
pp. 124-132 ◽  
Author(s):  
Hayato Koganei ◽  
Manabu Ueno ◽  
Shoji Tachikawa ◽  
Lisa Tasaki ◽  
Hyun Seung Ban ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document